Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
Cascadian Therapeutics received a pediatric waiver from the European Medicines Agency (EMA) for their lead candidate tucatinib, currently in a trial treating HER2+ metastatic breast cancer.
Cascadian Therapeutics (NASDAQ:CASC) received a pediatric waiver from the European Medicines Agency (EMA) for their lead candidate tucatinib, currently in a trial treating HER2+ metastatic breast cancer.
As quoted in the press release:
“This pediatric waiver is another important milestone in the European regulatory process, and will allow Cascadian to submit a marketing authorization application for tucatinib for the treatment of HER2+ metastatic breast cancer to the EMA following completion of the HER2CLIMB pivotal trial, without the requirement to conduct clinical studies in the pediatric population prior to approval or post-approval,” said Scott D. Myers, President and Chief Executive Officer of Cascadian Therapeutics.
As part of the regulatory process for the registration of new medicines with the EMA, pharmaceutical companies are required to have in place an approved Pediatric Investigation Plan (PIP) prior to MAA filing that outlines the clinical development strategy for studying the investigational product in the pediatric population. In some instances, a waiver from required pediatric studies for certain conditions may be granted by the EMA when development of a medicine for use in children is not feasible or appropriate.
Click here to read the full press release.
Source: globenewswire.com
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1842.49 | +26.31 | |
Silver | 21.91 | +0.58 | |
Copper | 4.28 | -0.01 | |
Palladium | 2016.00 | +31.00 | |
Platinum | 963.63 | +34.63 | |
Oil | 111.44 | -0.77 | |
Heating Oil | 3.66 | -0.01 | |
Natural Gas | 8.12 | -0.19 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.